On the issue of post COVID-19 condition in patients with rheumatic diseases

Actual problems of rheumatology include the possibility of developing a wide range of long-term consequences of COVID-19, so-called post-COVID syndrome (PCS). The results of our own research are presented, during which among 45 patients over 18 years with rheumatic diseases (RD) PCS was detected in...

Full description

Bibliographic Details
Main Authors: M. F. Beketova, V. V. Babak, M. D. Suprun, T. V. Beketova, O. A. Georginova
Format: Article
Language:Russian
Published: IMA PRESS LLC 2022-05-01
Series:Научно-практическая ревматология
Subjects:
Online Access:https://rsp.mediar-press.net/rsp/article/view/3148
_version_ 1797862603819581440
author M. F. Beketova
V. V. Babak
M. D. Suprun
T. V. Beketova
O. A. Georginova
author_facet M. F. Beketova
V. V. Babak
M. D. Suprun
T. V. Beketova
O. A. Georginova
author_sort M. F. Beketova
collection DOAJ
description Actual problems of rheumatology include the possibility of developing a wide range of long-term consequences of COVID-19, so-called post-COVID syndrome (PCS). The results of our own research are presented, during which among 45 patients over 18 years with rheumatic diseases (RD) PCS was detected in 20% cases: 6 of them had ANCAassociated vasculitis (AAV) and one each for rheumatoid arthritis, juvenile arthritis and osteoarthritis. In AAV cases PCS was more severe and varied than in other RD: lung lesions according to computed tomography (up to the damage 75% of the lung parenchyma), skin an d nervous (Guillain–Barré syndrome) lesions, myalgias, arthralgias were present. In most patients PCS ended in recovery, sudden death occurred only in the patient with AAV. The frequency of RD’s relapses in patients with PCS was 9%. Relapses were not noted in AAV, against the background of anti-B cell therapy with rituximab. Our own results and literature data indicate that patients with RD after COVID-19 need careful continuous monitoring to detect long-term complications of coronavirus infection and early diagnosis of relapses of the underlying disease.
first_indexed 2024-04-09T22:22:02Z
format Article
id doaj.art-bf65b8e9c6a641528421f07276d49156
institution Directory Open Access Journal
issn 1995-4484
1995-4492
language Russian
last_indexed 2024-04-09T22:22:02Z
publishDate 2022-05-01
publisher IMA PRESS LLC
record_format Article
series Научно-практическая ревматология
spelling doaj.art-bf65b8e9c6a641528421f07276d491562023-03-22T13:45:57ZrusIMA PRESS LLCНаучно-практическая ревматология1995-44841995-44922022-05-0160216216410.47360/1995-4484-2022-162-1642792On the issue of post COVID-19 condition in patients with rheumatic diseasesM. F. Beketova0V. V. Babak1M. D. Suprun2T. V. Beketova3O. A. Georginova4Lomonosov Moscow State UniversityV.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of Rheumatology; Central Clinical Hospital of the Administrative Directorate of the President of the Russian FederationLomonosov Moscow State UniversityActual problems of rheumatology include the possibility of developing a wide range of long-term consequences of COVID-19, so-called post-COVID syndrome (PCS). The results of our own research are presented, during which among 45 patients over 18 years with rheumatic diseases (RD) PCS was detected in 20% cases: 6 of them had ANCAassociated vasculitis (AAV) and one each for rheumatoid arthritis, juvenile arthritis and osteoarthritis. In AAV cases PCS was more severe and varied than in other RD: lung lesions according to computed tomography (up to the damage 75% of the lung parenchyma), skin an d nervous (Guillain–Barré syndrome) lesions, myalgias, arthralgias were present. In most patients PCS ended in recovery, sudden death occurred only in the patient with AAV. The frequency of RD’s relapses in patients with PCS was 9%. Relapses were not noted in AAV, against the background of anti-B cell therapy with rituximab. Our own results and literature data indicate that patients with RD after COVID-19 need careful continuous monitoring to detect long-term complications of coronavirus infection and early diagnosis of relapses of the underlying disease.https://rsp.mediar-press.net/rsp/article/view/3148post-covid syndromelong-covidcovid-19coronavirus disease 2019rheumatic diseasesanca-associated vasculitis
spellingShingle M. F. Beketova
V. V. Babak
M. D. Suprun
T. V. Beketova
O. A. Georginova
On the issue of post COVID-19 condition in patients with rheumatic diseases
Научно-практическая ревматология
post-covid syndrome
long-covid
covid-19
coronavirus disease 2019
rheumatic diseases
anca-associated vasculitis
title On the issue of post COVID-19 condition in patients with rheumatic diseases
title_full On the issue of post COVID-19 condition in patients with rheumatic diseases
title_fullStr On the issue of post COVID-19 condition in patients with rheumatic diseases
title_full_unstemmed On the issue of post COVID-19 condition in patients with rheumatic diseases
title_short On the issue of post COVID-19 condition in patients with rheumatic diseases
title_sort on the issue of post covid 19 condition in patients with rheumatic diseases
topic post-covid syndrome
long-covid
covid-19
coronavirus disease 2019
rheumatic diseases
anca-associated vasculitis
url https://rsp.mediar-press.net/rsp/article/view/3148
work_keys_str_mv AT mfbeketova ontheissueofpostcovid19conditioninpatientswithrheumaticdiseases
AT vvbabak ontheissueofpostcovid19conditioninpatientswithrheumaticdiseases
AT mdsuprun ontheissueofpostcovid19conditioninpatientswithrheumaticdiseases
AT tvbeketova ontheissueofpostcovid19conditioninpatientswithrheumaticdiseases
AT oageorginova ontheissueofpostcovid19conditioninpatientswithrheumaticdiseases